Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014

Saved in:
Bibliographic Details
Corporate Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format: Book
Language:English
Published: Washington : U.S. Government Publishing Office, 2016
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

Government Documents

Holdings details from Government Documents
Call Number: GovDocs Y 4.C 73/8:113-132
Available